Comparative Genetics: Synergizing Human and NOD Mouse Studies for Identifying Genetic Causation of Type 1 Diabetes
- 1 January 2012
- journal article
- research article
- Published by Raiya Academic International LLC in The Review of Diabetic Studies
- Vol. 9 (4) , 169-187
Abstract
Although once widely anticipated to unlock how human type 1 diabetes (T1D) develops, extensive study of the nonobese diabetic (NOD) mouse has failed to yield effective treatments for patients with the disease. This has led many to question the usefulness of this animal model. While criticism about the differences between NOD and human T1D is legitimate, in many cases disease in both species results from perturbations modulated by the same genes or different genes that function within the same biological pathways. Like in humans, unusual polymorphisms within an MHC class II molecule contributes the most T1D risk in NOD mice. This insight supports the validity of this model and suggests the NOD has been improperly utilized to study how to cure or prevent disease in patients. Indeed, clinical trials are far from administering T1D therapeutics to humans at the same concentration ranges and pathological states that inhibit disease in NOD mice. Until these obstacles are overcome it is premature to label the NOD mouse a poor surrogate to test agents that cure or prevent T1D. An additional criticism of the NOD mouse is the past difficulty in identifying genes underlying T1D using conventional mapping studies. However, most of the few diabetogenic alleles identified to date appear relevant to the human disorder. This suggests that rather than abandoning genetic studies in NOD mice, future efforts should focus on improving the efficiency with which diabetes susceptibility genes are detected. The current review highlights why the NOD mouse remains a relevant and valuable tool to understand the genes and their interactions that promote autoimmune diabetes and therapeutics that inhibit this disease. It also describes a new range of technologies that will likely transform how the NOD mouse is used to uncover the genetic causes of T1D for years to come.Keywords
This publication has 100 references indexed in Scilit:
- RNA-Seq: a revolutionary tool for transcriptomicsNature Reviews Genetics, 2009
- Commonalities of genetic resistance to spontaneous autoimmune and free radical-mediated diabetesFree Radical Biology and Medicine, 2008
- The ground state of embryonic stem cell self-renewalNature, 2008
- mt-Nd2 Suppresses Reactive Oxygen Species Production by Mitochondrial Complexes I and IIIJournal of Biological Chemistry, 2008
- Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunityNature Genetics, 2007
- Nuclear and Mitochondrial Interaction Involving mt-Nd2 Leads to Increased Mitochondrial Reactive Oxygen Species ProductionJournal of Biological Chemistry, 2007
- Conditioning the genome identifies additional diabetes resistance loci in Type I diabetes resistant NOR/Lt miceGenes & Immunity, 2005
- Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide–based retroviral vectorNature Biotechnology, 2004
- Substitution of aspartic acid at β57 with alanine alters MHC class II peptide binding activity but not protein stability: HLA-DQ (α1∗0201, β1∗0302) and (α1∗0201, β1∗0303)Human Immunology, 1999
- Linkage of type I diabetes to 15q26 (IDDM3) in the Danish populationHuman Genetics, 1996